The experimental results showed that miR-34a was delivered by the scFv targeted NLCs efficiently induced tumor cell apoptosis and inhibited tumor cell migration in vivo, which was associated with the downregulation of survivin and the inhibition of the MAPK pathway. This evidence concerns the gene BIRC5 and neoplasm.